Indian Institute of Public Health Gandhinagar , Gandhinagar, India.
University of Canberra , Bruce, Australia.
Hum Vaccin Immunother. 2020 Dec 1;16(12):2932-2937. doi: 10.1080/21645515.2020.1826249. Epub 2020 Nov 11.
The COVID-19 pandemic has imposed unprecedented health and socioeconomic challenges on public health, disrupting it on a global scale. Given that women and children are widely considered the most vulnerable in the times of emergency, whether in war or during a pandemic, the current pandemic has also severely disrupted access to reproductive and child health services. Despite this, data on the effect of the pandemic on pregnant women and newborns remain scarce, and gender-disaggregated indicators of mortality and morbidity are not available. In this context, we suggest the implementation of a gendered approach to ensure the specific needs of women and their newborns are considered during the development of COVID-19 vaccines. Taking into account gender-based biological differences, the inclusion of pregnant and lactating mothers in clinical trials for the development of COVID-19 vaccines is of vital importance.
新冠疫情大流行给全球公共卫生带来了前所未有的健康和社会经济挑战。鉴于在紧急情况下，妇女和儿童通常被认为是最脆弱的群体，无论是在战争时期还是大流行时期，当前的大流行也严重扰乱了生殖和儿童保健服务的获取。尽管如此，关于疫情对孕妇和新生儿影响的数据仍然稀缺，也没有按性别分类的死亡率和发病率指标。在这种情况下，我们建议采取一种基于性别的方法，以确保在开发新冠疫苗时考虑到妇女及其新生儿的特殊需求。考虑到基于性别的生物差异，将孕妇和哺乳期母亲纳入新冠疫苗研发的临床试验至关重要。
